ProShare Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-40,810
| Closed | -$3.47M | – | 2110 |
|
|
2020
Q3 | $3.47M | Buy |
40,810
+560
| +1% | +$28.3K | 0.02% | 457 |
|
|
2020
Q2 | $1.43M | Sell |
40,250
-821
| -2% | -$24K | 0.01% | 624 |
|
|
2020
Q1 | $554K | Sell |
41,071
-28,855
| -41% | -$486K | ﹤0.01% | 714 |
|
|
2019
Q4 | $1.48M | Sell |
69,926
-5,943
| -8% | -$105K | 0.01% | 685 |
|
|
2019
Q3 | $1.01M | Sell |
75,869
-110
| -0.1% | -$1.62K | 0.01% | 742 |
|
|
2019
Q2 | $1.05M | Sell |
75,979
-12,087
| -14% | -$182K | 0.01% | 744 |
|
|
2019
Q1 | $1.69M | Buy |
88,066
+3,132
| +4% | +$50.5K | 0.01% | 638 |
|
|
2018
Q4 | $1.21M | Sell |
84,934
-14,376
| -14% | -$285K | 0.01% | 667 |
|
|
2018
Q3 | $2.07M | Buy |
99,310
+11,620
| +13% | +$275K | 0.01% | 593 |
|
|
2018
Q2 | $2.08M | Sell |
87,690
-2,028
| -2% | -$40.8K | 0.01% | 615 |
|
|
2018
Q1 | $1.31M | Sell |
89,718
-7,357
| -8% | -$120K | 0.01% | 732 |
|
|
2017
Q4 | $1.57M | Buy |
97,075
+27,371
| +39% | +$323K | 0.01% | 681 |
|
|
2017
Q3 | $974K | Buy |
69,704
+4,114
| +6% | +$41K | 0.01% | 739 |
|
|
2017
Q2 | $579K | Sell |
65,590
-2,241
| -3% | -$15.7K | 0.01% | 905 |
|
|
2017
Q1 | $439K | Sell |
67,831
-17,807
| -21% | -$90.2K | ﹤0.01% | 1053 |
|
|
2016
Q4 | $314K | Buy |
85,638
+16,610
| +24% | +$49.1K | ﹤0.01% | 1336 |
|
|
2016
Q3 | $224K | Sell |
69,028
-12,218
| -15% | -$34.2K | ﹤0.01% | 1299 |
|
|
2016
Q2 | $188K | Sell |
81,246
-690
| -0.8% | -$2.31K | ﹤0.01% | 1437 |
|
|
2016
Q1 | $205K | Sell |
81,936
-8,216
| -9% | -$18.5K | ﹤0.01% | 1406 |
|
|
2015
Q4 | $277K | Buy |
90,152
+8,780
| +11% | +$24.5K | ﹤0.01% | 1333 |
|
|
2015
Q3 | $140K | Sell |
81,372
-5,480
| -6% | -$14K | ﹤0.01% | 1365 |
|
|
2015
Q2 | $353K | Sell |
86,852
-4,366
| -5% | -$17.9K | ﹤0.01% | 1239 |
|
|
2015
Q1 | $349K | Buy |
91,218
+11,812
| +15% | +$51.4K | ﹤0.01% | 1382 |
|
|
2014
Q4 | $381K | Sell |
79,406
-1,390
| -2% | -$5.5K | ﹤0.01% | 1356 |
|
|
2014
Q3 | $301K | Sell |
80,796
-15,603
| -16% | -$52.7K | ﹤0.01% | 1719 |
|
|
2014
Q2 | $352K | Sell |
96,399
-41,594
| -30% | -$153K | ﹤0.01% | 1798 |
|
|
2014
Q1 | $581K | Buy |
137,993
+96,042
| +229% | +$476K | 0.01% | 1749 |
|
|
2013
Q4 | $193K | Sell |
41,951
-33,500
| -44% | -$149K | ﹤0.01% | 1262 |
|
|
2013
Q3 | $467K | Buy |
75,451
+12,741
| +20% | +$73.3K | 0.01% | 1532 |
|
|
2013
Q2 | $341K | Buy |
+62,710
| New | +$206K | 0.01% | 1607 |
|
ProShare Advisors's IMMU Position: Q4 2020 in Review
ProShare Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 40,810 shares — an estimated $3.47M sold.
ProShare Advisors first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $3.47M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- ProShare Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- ProShare Advisors sold 40,810 Immunomedics Inc shares in Q4 2020, an estimated $3.47M.
- ProShare Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- ProShare Advisors's Immunomedics Inc position peaked at $3.47M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on ProShare Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.